AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-100 | >>
Results: 26-50/109
FUNCTIONAL ASSAY OF MULTIDRUG-RESISTANT CELLS USING JC-1, A CARBOCYANINE FLUORESCENT-PROBE
Authors: KUHNEL JM PERROT JY FAUSSAT AM MARIE JP SCHWALLER MA
Citation: Jm. Kuhnel et al., FUNCTIONAL ASSAY OF MULTIDRUG-RESISTANT CELLS USING JC-1, A CARBOCYANINE FLUORESCENT-PROBE, Leukemia, 11(7), 1997, pp. 1147-1155
DIAGNOSTIC AND THERAPEUTIC STRATEGIES
Authors: MARIE JP SIMON D BAUMELOU E BELLUCCI S BIERLING P BORDESOULE D LEBLANC T LEPORRIER M MICLEA JM NAJEAN Y RAIN JD ROHRLICH P SCHVED JF VARET B ZITTOUN R
Citation: Jp. Marie et al., DIAGNOSTIC AND THERAPEUTIC STRATEGIES, La Presse medicale, 26(9), 1997, pp. 433-438
DISCREPANCIES BETWEEN HEPARIN-PLATELET-INDUCED ANTIBODIES (HPIA) TESTAND PLATELET-AGGREGATION TEST (PAT) - OTHER TARGET FOR HEPARIN-INDUCED ANTIBODIES
Authors: ELALAMY I LECRUBIER C AMIRAL J POTEVIN F MARIE JP SAMAMA MM
Citation: I. Elalamy et al., DISCREPANCIES BETWEEN HEPARIN-PLATELET-INDUCED ANTIBODIES (HPIA) TESTAND PLATELET-AGGREGATION TEST (PAT) - OTHER TARGET FOR HEPARIN-INDUCED ANTIBODIES, Thrombosis and haemostasis, 1997, pp. 1833-1833
A COMPARISON BETWEEN A STANDARDIZED PLATELET-AGGREGATION TEST AND THEPLATELET FACTOR-4 HEPARIN ENZYME-LINKED-IMMUNOSORBENT-ASSAY IN A SERIES OF 183 CONSECUTIVE PATIENTS
Authors: ELALAMY I POTEVIN F LECRUBIER C MARIE JP SAMAMA MM
Citation: I. Elalamy et al., A COMPARISON BETWEEN A STANDARDIZED PLATELET-AGGREGATION TEST AND THEPLATELET FACTOR-4 HEPARIN ENZYME-LINKED-IMMUNOSORBENT-ASSAY IN A SERIES OF 183 CONSECUTIVE PATIENTS, Thrombosis and haemostasis, 1997, pp. 1841-1841
A STRONG EXPRESSION OF CD44-6V IS ASSOCIATED WITH POOR-PROGNOSIS IN ACUTE MYELOID-LEUKEMIA
Authors: LEGRAS S GUNTHERT U STAUDER R CURT F OLIFERENKO S KLUINNELEMANS C MARIE JP VERNANT JP SMADJAJOFFE F
Citation: S. Legras et al., A STRONG EXPRESSION OF CD44-6V IS ASSOCIATED WITH POOR-PROGNOSIS IN ACUTE MYELOID-LEUKEMIA, Experimental hematology, 25(8), 1997, pp. 479-479
GLUTATHIONE SYSTEM, TOPOISOMERASE-II LEVEL AND MULTIDRUG-RESISTANCE PHENOTYPE IN ACUTE MYELOGENOUS LEUKEMIA BEFORE TREATMENT AND AT RELAPSE
Authors: MASSAADMASSADE L RIBRAG V MARIE JP FAUSSAT AM BAYLE C DREYFUS F GOUYETTE A
Citation: L. Massaadmassade et al., GLUTATHIONE SYSTEM, TOPOISOMERASE-II LEVEL AND MULTIDRUG-RESISTANCE PHENOTYPE IN ACUTE MYELOGENOUS LEUKEMIA BEFORE TREATMENT AND AT RELAPSE, Anticancer research, 17(6D), 1997, pp. 4647-4651
TRANSVENOUS VERSUS PERINERVOUS STIMULATION OF THE PHRENIC-NERVE TO ASSESS THE DIAPHRAGMATIC STRENGTH IN RABBITS
Authors: MARIE JP TARDIF C GIBON JF LEROSEY Y HELLOT MF PASQUIS P DEHESDIN D
Citation: Jp. Marie et al., TRANSVENOUS VERSUS PERINERVOUS STIMULATION OF THE PHRENIC-NERVE TO ASSESS THE DIAPHRAGMATIC STRENGTH IN RABBITS, Journal of neuroscience methods, 76(2), 1997, pp. 135-141
MEASURING MULTIDRUG-RESISTANCE EXPRESSION IN HUMAN MALIGNANCIES - ELABORATION OF CONSENSUS RECOMMENDATIONS
Authors: MARIE JP LEGRAND O PERROT JY CHEVILLARD S HUET S ROBERT J
Citation: Jp. Marie et al., MEASURING MULTIDRUG-RESISTANCE EXPRESSION IN HUMAN MALIGNANCIES - ELABORATION OF CONSENSUS RECOMMENDATIONS, Seminars in hematology, 34(4), 1997, pp. 63-71
SELECTIVE RESECTION OF THE PHRENIC-NERVE ROOTS IN RABBITS .1. CARTOGRAPHY OF THE RESIDUAL INNERVATION
Authors: MARIE JP LAQUERRIERE A LEROSEY Y BODENANT C TARDIF C HEMET J TADIE M ANDRIEUGUITRANCOURT J DEHESDIN D
Citation: Jp. Marie et al., SELECTIVE RESECTION OF THE PHRENIC-NERVE ROOTS IN RABBITS .1. CARTOGRAPHY OF THE RESIDUAL INNERVATION, Respiration physiology, 109(2), 1997, pp. 127-138
SELECTIVE RESECTION OF THE PHRENIC-NERVE ROOTS IN RABBITS .2. RESPIRATORY EFFECTS
Authors: MARIE JP TARDIF C LEROSEY Y GIBON JF HELLOT MF TADIE M ANDRIEUGUITRANCOURT J DEHESDIN D PASQUIS P
Citation: Jp. Marie et al., SELECTIVE RESECTION OF THE PHRENIC-NERVE ROOTS IN RABBITS .2. RESPIRATORY EFFECTS, Respiration physiology, 109(2), 1997, pp. 139-148
NEW THERAPEUTIC APPROACHES IN ACUTE MYELOGENOUS LEUKEMIA (AML) AND CHRONIC MYELOGENOUS LEUKEMIA (CML)
Authors: MARIE JP
Citation: Jp. Marie, NEW THERAPEUTIC APPROACHES IN ACUTE MYELOGENOUS LEUKEMIA (AML) AND CHRONIC MYELOGENOUS LEUKEMIA (CML), Bulletin du cancer, 84(4), 1997, pp. 451-452
TREATMENT OF HAIRY-CELL LEUKEMIA (HCL) WITH 2-CHLORODEOXYADENOSINE (2-CDA) - IDENTIFICATION OF PARAMETERS PREDICTIVE OF ADVERSE-EFFECTS
Authors: LEGRAND O VEKHOFF A MARIE JP ZITTOUN R DELMER A
Citation: O. Legrand et al., TREATMENT OF HAIRY-CELL LEUKEMIA (HCL) WITH 2-CHLORODEOXYADENOSINE (2-CDA) - IDENTIFICATION OF PARAMETERS PREDICTIVE OF ADVERSE-EFFECTS, British Journal of Haematology, 99(1), 1997, pp. 165-167
PROGNOSTIC FACTORS IN ELDERLY ACUTE LYMPHOBLASTIC-LEUKEMIA
Authors: LEGRAND O MARIE JP MARJANOVIC Z CADIOU M BLANC C RAMOND S VIGUIE F PERROT JY ZITTOUN R
Citation: O. Legrand et al., PROGNOSTIC FACTORS IN ELDERLY ACUTE LYMPHOBLASTIC-LEUKEMIA, British Journal of Haematology, 97(3), 1997, pp. 596-602
REGULATION OF E2F-4 TRANSCRIPTION FACTOR IN THE EARLY PHASES OF THE CELL-CYCLE
Authors: SUZAN F LEVY V RADOSEVIC N TANG RP MARIE JP ZITTOUN R DELMER A AJCHENBAUMCYMBALISTA F
Citation: F. Suzan et al., REGULATION OF E2F-4 TRANSCRIPTION FACTOR IN THE EARLY PHASES OF THE CELL-CYCLE, Blood, 90(10), 1997, pp. 204-204
A STRONG EXPRESSION OF CD44-6 V CELL-SURFACE PROTEIN CORRELATES WITH SHORTER SURVIVAL IN ACUTE MYELOID-LEUKEMIA
Authors: LEGRAS S GUNTHERT U STAUDER R CURT F OLIFERENKO S KLUINNELEMANS JC MARIE JP PROCTOR S JASMIN C SMADJAJOFFE F
Citation: S. Legras et al., A STRONG EXPRESSION OF CD44-6 V CELL-SURFACE PROTEIN CORRELATES WITH SHORTER SURVIVAL IN ACUTE MYELOID-LEUKEMIA, Blood, 90(10), 1997, pp. 282-282
THE EXPRESSION OF CELL-CYCLE INHIBITOR P27KIP1 HAS A PROGNOSTIC-SIGNIFICANCE AND INFLUENCES APOPTOSIS IN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA
Authors: VRHOVAC R DELMER A TANG RP MARIE JP ZITTOUN R AJCHENBAUMCYMBALISTA F
Citation: R. Vrhovac et al., THE EXPRESSION OF CELL-CYCLE INHIBITOR P27KIP1 HAS A PROGNOSTIC-SIGNIFICANCE AND INFLUENCES APOPTOSIS IN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA, Blood, 90(10), 1997, pp. 399-399
COMPARISON OF MDR1, MRP AND LRP EXPRESSION WITH IN-VITRO DRUG-SENSITIVITY AND IN-VIVO RESPONSE TO TREATMENT IN FRESH BLAST CELLS FROM ADULTACUTE MYELOID-LEUKEMIA PATIENTS
Authors: LEGRAND O SIMONIN G ZITTOUN R MARIE JP
Citation: O. Legrand et al., COMPARISON OF MDR1, MRP AND LRP EXPRESSION WITH IN-VITRO DRUG-SENSITIVITY AND IN-VIVO RESPONSE TO TREATMENT IN FRESH BLAST CELLS FROM ADULTACUTE MYELOID-LEUKEMIA PATIENTS, Blood, 90(10), 1997, pp. 797-797
MOLECULAR EVALUATION OF CONSOLIDATION THERAPY AND EARLY ALLOGRAFT OR AUTOGRAFT FOR BCR-ABL(POS) ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) PATIENTS - A PILOT-STUDY OF EIGLE (EUROPEAN INTERGROUP OF GIMEMA, FRENCHLALA AND EORTC)
Authors: STRYCKMANS P SUCIU S ANNINO L SAGLIO G MUUS P MARIE JP DOMBRET H GAMBERT J SOLBU G DARDENNE M MANDELLI F FIERE D
Citation: P. Stryckmans et al., MOLECULAR EVALUATION OF CONSOLIDATION THERAPY AND EARLY ALLOGRAFT OR AUTOGRAFT FOR BCR-ABL(POS) ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) PATIENTS - A PILOT-STUDY OF EIGLE (EUROPEAN INTERGROUP OF GIMEMA, FRENCHLALA AND EORTC), Blood, 90(10), 1997, pp. 809-809
DEFECTIVE P21 EXPRESSION IN A HL-60 CELL-LINE RESISTANT TO DAUNORUBICIN
Authors: LEVY V TANG RP RADOSIEVIC N FAUSSAT AM MARIE JP DELMER A ZITTOUN R AJCHENBAUMCYMBALISTA F
Citation: V. Levy et al., DEFECTIVE P21 EXPRESSION IN A HL-60 CELL-LINE RESISTANT TO DAUNORUBICIN, Blood, 90(10), 1997, pp. 1402-1402
GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF) TO INCREASEEFFICACY OF INTENSIVE SEQUENTIAL CHEMOTHERAPY WITH MITOXANTRONE(M), ETOPOSIDE(E) AND CYTARABINE(A) IN PREVIOUSLY TREATED ACUTE MYELOID-LEUKEMIA (AML) - A MULTICENTER RANDOMIZED PLACEBO-CONTROLLED TRIAL
Authors: ARCHIMBAUD E FENAUX P DOMBRET H DREYFUS F TILLY H CONYMAKHOUL P LEBLOND V TROUSSARD X DELAIR S FFRENCH M MARIE JP
Citation: E. Archimbaud et al., GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF) TO INCREASEEFFICACY OF INTENSIVE SEQUENTIAL CHEMOTHERAPY WITH MITOXANTRONE(M), ETOPOSIDE(E) AND CYTARABINE(A) IN PREVIOUSLY TREATED ACUTE MYELOID-LEUKEMIA (AML) - A MULTICENTER RANDOMIZED PLACEBO-CONTROLLED TRIAL, Blood, 90(10), 1997, pp. 2250-2250
TIMED SEQUENTIAL CHEMOTHERAPY FOR ADVANCED ACUTE MYELOID-LEUKEMIA
Authors: ARCHIMBAUD E LEBLOND V FENAUX P DOMBRET H CORDONNIER C DREYFUS F CONYMAKHOUL P TILLY H TROUSSARD X AUZANNEAU G THOMAS X FFRENCH M MARIE JP
Citation: E. Archimbaud et al., TIMED SEQUENTIAL CHEMOTHERAPY FOR ADVANCED ACUTE MYELOID-LEUKEMIA, HEM CELL TH, 38(2), 1996, pp. 161-167
MDR1 P-GLYCOPROTEIN IN HEMATOLOGICAL NEOPLASMS/
Authors: MARIE JP ZHOU DC GURBUXANI S LEGRAND O ZITTOUN R
Citation: Jp. Marie et al., MDR1 P-GLYCOPROTEIN IN HEMATOLOGICAL NEOPLASMS/, European journal of cancer, 32A(6), 1996, pp. 1034-1038
A FATAL LOW-MOLECULAR-WEIGHT HEPARIN-ASSOCIATED THROMBOCYTOPENIA AFTER HIP-SURGERY - POSSIBLE USEFULNESS OF PF4-HEPARIN ELISA TEST
Authors: ELALAMY I POTEVIN F LECRUBIER C BARA L MARIE JP SAMAMA MM
Citation: I. Elalamy et al., A FATAL LOW-MOLECULAR-WEIGHT HEPARIN-ASSOCIATED THROMBOCYTOPENIA AFTER HIP-SURGERY - POSSIBLE USEFULNESS OF PF4-HEPARIN ELISA TEST, Blood coagulation & fibrinolysis, 7(7), 1996, pp. 665-671
REVERSAL OF MULTIDRUG-RESISTANCE BY SDZ PSC-833, COMBINED WITH VAD (VINCRISTINE, DOXORUBICIN, DEXAMETHASONE) IN REFRACTORY MULTIPLE-MYELOMA- A PHASE-I STUDY
Authors: SONNEVELD P MARIE JP HUISMAN C VEKHOFF A SCHOESTER M FAUSSAT AM VANKAPEL J GROENEWEGEN A CHARNICK S ZITTOUN R LOWENBERG B
Citation: P. Sonneveld et al., REVERSAL OF MULTIDRUG-RESISTANCE BY SDZ PSC-833, COMBINED WITH VAD (VINCRISTINE, DOXORUBICIN, DEXAMETHASONE) IN REFRACTORY MULTIPLE-MYELOMA- A PHASE-I STUDY, Leukemia, 10(11), 1996, pp. 1741-1750
ABNORMAL CHROMATIN CLUMPING IN POLYMORPHONUCLEARS FROM A PATIENT WITHAIDS
Authors: CIAUDO M RAMON S JAYLE D KAZATCHKINE M MARIE JP
Citation: M. Ciaudo et al., ABNORMAL CHROMATIN CLUMPING IN POLYMORPHONUCLEARS FROM A PATIENT WITHAIDS, American journal of hematology, 52(1), 1996, pp. 62-63
Risultati: 1-25 | 26-50 | 51-75 | 76-100 | >>